Researchers in UT Pharmacy's Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs have earned a bevy of national and international awards for their work in pharmaceutical drug delivery and 3D printing personalized medicines.
A university is only as great as its faculty and the College of Pharmacy went all-in on faculty excellence. On Wednesday, April 6, The University of Texas at Austin’s Pharmacy Council honored and celebrated top educators from across the college at its 2022 Teaching Excellence Awards.
Dr. Mo Maniruzzaman's Pharmaceutical Engineering and 3D Printing Labs have received a federal grant from the United States Agency for International Development (USAID) to develop personalized 3D printed non-hormonal intrauterine devices (IUDs). The project’s goal is to increase global access to long-term and effective contraception while minimizing some of its most debilitating side effects.
Student pharmacist Cara Rutledge (Pharm.D. Class of 2022) wrote an article for the Pharmacy Times about her honors program thesis which aimed to address the various complexities of student motivation, engagement and attendance in relation to mastery of course material.
UT student pharmacists Kailee Marikar, Sadaf Helforoosh, Hannah McCullough, Agaustin Wong and Cara Rutledge talked to the Pharmacy Times’ Skylar Kenney about their experiences balancing their studies in the midst of the pandemic and how COVID-19 showed a pharmacist's vital role in public health.
The College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs recently earned a three-year $1.5 million National Institutes of Health (NIH) R01 grant to research novel manufacturing technology for complex vaccine formulations for influenza and other emerging infectious diseases.
The college's Pharmaceutical Engineering and 3D Printing (PharmE3D) labs, led by Assistant Professor in Molecular Pharmaceutics and Drug Delivery Mohammed (Mo) Maniruzzaman, Ph.D., has recently earned several national and international awards and scholarships for outstanding research contributions to the field of pharmaceutical science and technology.
Division Head and Professor of Molecular Pharmaceutics and Drug Delivery Dr. Bill Williams was on KXAN News to talk about promising new data from TFF Pharmaceuticals and Augmenta Bioworks. The companies plan to develop Dr. Williams' thin film freezing technology to better deliver antibody treatment directly to the lungs of COVID patients.